3-33132671-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_006371.5(CRTAP):c.1039C>T(p.Leu347Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00306 in 1,614,124 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0025 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0031 ( 10 hom. )
Consequence
CRTAP
NM_006371.5 missense
NM_006371.5 missense
Scores
3
10
5
Clinical Significance
Conservation
PhyloP100: 7.80
Genes affected
CRTAP (HGNC:2379): (cartilage associated protein) The protein encoded by this gene is similar to the chicken and mouse CRTAP genes. The encoded protein is a scaffolding protein that may influence the activity of at least one member of the cytohesin/ARNO family in response to specific cellular stimuli. Defects in this gene are associated with osteogenesis imperfecta, a connective tissue disorder characterized by bone fragility and low bone mass. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.022593439).
BP6
Variant 3-33132671-C-T is Benign according to our data. Variant chr3-33132671-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 439559.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=4}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00247 (376/152312) while in subpopulation AMR AF= 0.00497 (76/15300). AF 95% confidence interval is 0.00407. There are 0 homozygotes in gnomad4. There are 154 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CRTAP | NM_006371.5 | c.1039C>T | p.Leu347Phe | missense_variant | 5/7 | ENST00000320954.11 | NP_006362.1 | |
CRTAP | NM_001393363.1 | c.1039C>T | p.Leu347Phe | missense_variant | 5/6 | NP_001380292.1 | ||
CRTAP | NM_001393364.1 | c.910C>T | p.Leu304Phe | missense_variant | 4/6 | NP_001380293.1 | ||
CRTAP | NM_001393365.1 | c.889C>T | p.Leu297Phe | missense_variant | 4/6 | NP_001380294.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CRTAP | ENST00000320954.11 | c.1039C>T | p.Leu347Phe | missense_variant | 5/7 | 1 | NM_006371.5 | ENSP00000323696.5 | ||
CRTAP | ENST00000449224.1 | c.910C>T | p.Leu304Phe | missense_variant | 4/6 | 2 | ENSP00000409997.1 |
Frequencies
GnomAD3 genomes AF: 0.00247 AC: 376AN: 152194Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
376
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00201 AC: 506AN: 251494Hom.: 1 AF XY: 0.00200 AC XY: 272AN XY: 135920
GnomAD3 exomes
AF:
AC:
506
AN:
251494
Hom.:
AF XY:
AC XY:
272
AN XY:
135920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00312 AC: 4557AN: 1461812Hom.: 10 Cov.: 40 AF XY: 0.00303 AC XY: 2207AN XY: 727222
GnomAD4 exome
AF:
AC:
4557
AN:
1461812
Hom.:
Cov.:
40
AF XY:
AC XY:
2207
AN XY:
727222
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00247 AC: 376AN: 152312Hom.: 0 Cov.: 32 AF XY: 0.00207 AC XY: 154AN XY: 74480
GnomAD4 genome
AF:
AC:
376
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
154
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
18
ALSPAC
AF:
AC:
16
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
33
ExAC
AF:
AC:
219
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Aug 01, 2024 | Reported in an individual with osteogenesis imperfecta who also has a pathogenic variant in the COL1A1 gene (PMID: 32169308); Identified in a patient with osteoporosis and relatives with osteopenia or osteoporosis (PMID: 35313637); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32169308, 35313637, 30389107, 33469725) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | CRTAP: BP4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 25, 2023 | BS1 - |
Osteogenesis imperfecta type 7 Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jun 28, 2023 | The CRTAP c.1039C>T; p.Leu347Phe variant (rs115198029), to our knowledge, is not reported in the medical literature; however, this variant is listed in the ClinVar database (Variation ID: 439559). This variant is found in the general population with an overall allele frequency of 0.20% (562/282,886 alleles, including a single homozygote) in the Genome Aggregation Database. The leucine at codon 347 is highly conserved, but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.354). Based on the available information, the clinical significance of this variant is uncertain. - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 20, 2017 | - - |
Osteogenesis imperfecta Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Feb 18, 2022 | - - |
CRTAP-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 29, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at